Starting this autumn, the drug packaging requirements may change. The start of a pilot project was announced for September. Several companies and drugs from the Affordable Medicines Program will join it. In order for this scheme to work fully, the regulator needs to do a lot of work (it took almost 10 years in EU), first of all, to create a legal framework.
If the pilot initiative happens to be successful, manufacturers will need to integrate special codes into the packaging design, by scanning which patients will be able to independently verify the drugs using a mobile application. The Ministry of Economic Development and Trade is engaged in its development.
A special 2D code will be printed on the drug packaging. It will be applied during manufacturing at the plant, and the data will be entered into a single governmental system for drugs circulation monitoring.
After scanning, information about the drugs will appear on the screen. Particularly, you will know whether the drug is falsified, expired or imported into the country in violation.
In addition, coding will allow to track the entire supply chain of drugs, from manufacturing or importing to sale at a pharmacy. It will also help to respond timely to violations. All transactions will be included in a single database, including a batch of drugs and a manufacturing date.